The Goldman Sachs Group, Inc. GS is on track for a historic year in mergers and acquisitions (M&A), potentially not seen since the early 2000s, as deal-making accelerates. GS has continued to maintain ...

The biotech sector, represented by the iShares Biotechnology ETF, has experienced a notable rally in recent months. The key driver of the 40% over the past six months has been a notable uptick in M&A ...

Goldman controls 34% of 2025’s $3.8T in global M&A. Landmark deals like EA’s $55B take-private fuel its lead. Advisory revenue is projected to hit $4.72B, up 34% year over year. Goldman Sachs is ...

In the third quarter of 2025, the transport sector witnessed a continued decline in merger and acquisition (M&A) activity, marking the third consecutive quarter of reduced deal volume. This downward ...